Champions Oncology, Inc. (CSBR)
6.09
-0.11
(-1.77%)
USD |
NASDAQ |
Mar 18, 15:59
6.09
0.00 (0.00%)
After-Hours: 20:00
Champions Oncology EPS Diluted (Quarterly) : -0.0201 for Jan. 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | -0.301 |
| Curis, Inc. | -0.4929 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
| Enzon Pharmaceuticals, Inc. | -0.0216 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.279M |
| Revenue (Quarterly) | 16.56M |
| Total Expenses (Quarterly) | 16.84M |
| Enterprise Value | 84.06M |
| Gross Profit Margin (Quarterly) | 44.59% |
| Profit Margin (Quarterly) | -1.68% |
| Earnings Yield | -2.74% |
| Normalized Earnings Yield | -2.736 |